Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Corcept Therapeutics Incorporated - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CORT
Nasdaq
2830
www.corcept.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Corcept Therapeutics Incorporated
3 Growth Companies With High Insider Ownership Seeing Up To 94% Earnings Growth
- Jun 8th, 2026 11:36 am
CORT Stock Rises 42% in a Month: Here's What You Should Know
- Jun 8th, 2026 10:01 am
Insider Favorites High Growth Companies June 2026
- Jun 8th, 2026 5:35 am
Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®
- Jun 6th, 2026 2:45 pm
Top Growth Companies With Insider Ownership In June 2026
- Jun 5th, 2026 11:35 am
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?
- Jun 5th, 2026 9:30 am
Growth Companies With High Insider Ownership And Up To 30% Return On Equity
- Jun 5th, 2026 5:36 am
June 2026 Growth Stocks With High Insider Ownership
- Jun 4th, 2026 5:35 am
Top Growth Companies With Significant Insider Stakes June 2026
- Jun 3rd, 2026 11:35 am
Spotlight On AppLovin And 2 More Growth Stocks With Significant Insider Stakes
- Jun 3rd, 2026 5:35 am
3 Growth Companies With High Insider Ownership And Up To 114% Earnings Growth
- Jun 2nd, 2026 11:35 am
3 Growth Companies With High Insider Ownership Expecting 67% Earnings Growth
- Jun 2nd, 2026 5:35 am
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Question
- Jun 1st, 2026 3:36 pm
June 2026's Leading Growth Stocks With Insider Influence
- Jun 1st, 2026 11:36 am
3 Growth Stocks Insiders Are Betting On
- Jun 1st, 2026 5:36 am
Corcept Presents New Data at ASCO 2026: Lifyorli™ Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure
- May 29th, 2026 2:33 pm
3 Growth Stocks With Strong Insider Confidence
- May 29th, 2026 11:36 am
High Insider Stakes In Leading Growth Companies May 2026
- May 29th, 2026 5:36 am
High Insider Ownership Growth Stocks To Watch In May 2026
- May 28th, 2026 11:35 am
CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up
- May 28th, 2026 8:11 am
Scroll